Milestone Scientific Inc (AMEX:MLSS)
$ 0.50 -0.058 (-10.47%) Market Cap: 43.94 Mil Enterprise Value: 42.48 Mil PE Ratio: 0 PB Ratio: 12.69 GF Score: 37/100

Q3 2024 Milestone Scientific Inc Earnings Call Transcript

Nov 15, 2024 / 01:30PM GMT
Release Date Price: $0.65 (-4.31%)

Key Points

Positve
  • Milestone Scientific Inc (MLSS) achieved a 22% increase in year-over-year revenue, reaching $2.5 million, primarily driven by strong growth in the dental division.
  • International dental sales increased by 57% as logistics challenges were resolved, contributing to higher revenue.
  • The shift to an e-commerce sales model domestically has strengthened gross margins, which remain high at 73%.
  • The CompuFlo Epidural System has gained traction with respected clinics adopting the technology, enhancing its market presence.
  • The company has secured Medicare Part B physician payment rate assignment for the CompuFlo Epidural System, expanding its financial accessibility and market potential.
Negative
  • Milestone Scientific Inc (MLSS) recorded no revenue from China for the third quarter, impacting overall international sales.
  • Despite revenue growth, the company reported an operating loss of approximately $1.5 million for the third quarter.
  • International revenue for the nine months ending September 30, 2024, decreased by $0.6 million compared to the same period in 2023.
  • The company faces challenges in expanding its JMAC coverage, which is crucial for broader adoption of the CompuFlo Epidural System.
  • There is a need for continuous efforts to convert sales leads into actual sales, which requires significant resources and time.
Operator

Good morning, everyone. Welcome to the Milestone Scientific's third-quarter 2024 financial results and business update conference call. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to your host, David Waldman, Crescendo Communications. David, the floor is yours.

David Waldman
Crescendo Communications LLC - Investor Relations

Thank you, Jenny. Good morning, and thank you all for joining Milestone Scientific's third-quarter 2024 financial results conference call. On the call with us today are Neil Goldman, Chairman of the Board; Arjan Haverhals, Chief Executive Officer; and Keisha Harcum, Vice President, Finance of Milestone Scientific.

The company issued a press release yesterday afternoon containing third-quarter 2024 financial results, which is also posted on the company's website. (Event Instructions) Company's management will now provide prepared remarks for you in the financial and operational results for the third quarter ended September 30, 2024.

Before we get

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot